Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

Authors

  • Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party


  • Co-chairs:
    GW McCaughan, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia
    M Omata, Tokyo University Hospital, Tokyo, Japan
    Faculty Members:
    D Amarapurkar, Bombay Hospital, Mumbai, India
    S Bowden, Victorian Infectious Diseases Reference Laboratories, Melbourne, Australia
    WC Chow, Singapore General Hospital, Singapore
    A Chutaputti, Pramongkutklao Hospital, Bangkok, Thailand
    G Dore, National Center in HIV Epidemiology and Clinical Research, Sydney, Australia
    E Gane, NZ Liver Transplant Unit, Auckland, New Zealand
    R Guan, Mount Elizabeth Medical Center, Singapore
    SS Hamid, The Aga Khan University, Karachi, Pakistan
    W Hardikar, Royal Children's Hospital, Melbourne, Australia
    CK Hui, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
    W Jafri, The Aga Khan University, Karachi, Pakistan
    J-D Jia, Beijing Friendship Hospital, Capital Medical University, Beijing, China
    M-Y Lai, National Taiwan University Hospital, Taiwan
    L Wei, Peking University Peoples Hospital, Beijing, China
    N Leung, The Chinese University of Hong Kong, Hong Kong, China
    T Piratvisuth, Prince of Songkla University, Hat Yai, Thailand
    S Sarin, GB Pant Hospital, Delhi, India
    J Sollano, University Santo Tomas Hospital, Manilla, Philippines
    R Tateishi, University of Tokyo Hospital, Tokyo Japan

Professor GW McCaughan, Centenary Research Institute, AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, University of Sydney, NSW 2006, Australia. Email: g.mccaughan@centenary.usyd.edu.au

No abstract is available for this article.

Ancillary